Ameritas Investment Partners, Inc. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$13,000
-40.9%
5,0100.0%0.00%
-100.0%
Q4 2021$22,000
-15.4%
5,0100.0%0.00%0.0%
Q3 2021$26,000
-18.8%
5,0100.0%0.00%0.0%
Q2 2021$32,000
-17.9%
5,0100.0%0.00%0.0%
Q1 2021$39,000
+62.5%
5,010
+35.8%
0.00%0.0%
Q4 2020$24,000
-4.0%
3,6890.0%0.00%0.0%
Q3 2020$25,000
-19.4%
3,6890.0%0.00%0.0%
Q2 2020$31,000
+10.7%
3,6890.0%0.00%
-50.0%
Q1 2020$28,000
-9.7%
3,6890.0%0.00%
+100.0%
Q4 2019$31,000
+14.8%
3,6890.0%0.00%0.0%
Q3 2019$27,000
-34.1%
3,6890.0%0.00%
-50.0%
Q2 2019$41,000
+2.5%
3,6890.0%0.00%0.0%
Q1 2019$40,000
-18.4%
3,689
+13.9%
0.00%
-33.3%
Q4 2018$49,000
-18.3%
3,2390.0%0.00%0.0%
Q3 2018$60,000
-18.9%
3,2390.0%0.00%
-25.0%
Q2 2018$74,000
+1.4%
3,239
+27.0%
0.00%0.0%
Q1 2018$73,000
+35.2%
2,5500.0%0.00%
+100.0%
Q4 2017$54,000
+22.7%
2,5500.0%0.00%0.0%
Q3 2017$44,000
+10.0%
2,5500.0%0.00%0.0%
Q2 2017$40,000
+48.1%
2,550
+60.3%
0.00%
+100.0%
Q1 2017$27,0001,5910.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders